For instance, the combination of Sulodexide and Jinshuibao has been shown to confer benefits in early diabetic nephropathy by simultaneously improving oxidative stress and inflammatory markers 11 , Glucagon-Like Peptide-1 (GLP-1) receptor agonists improve hepatic lipid metabolism through the AMP-activated protein kinase (AMPK)/Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1) pathway 12,13,14 , Given the complex, multi-system nature of T2DM/MASLD, there is a clear unmet need for multi-target agents capable of blocking the metabolic-inflammatory-fibrotic cascade, which single-pathway interventions often fail to address
Work focuses on pathway mapping, assay development, and peptide SAR exclusively in controlled, non-clinical in-vitro environments
Several motor and non-motor symptoms appearing with this disease are linked to reduction in dopamine levels
Control acute inflammation early
The rate of occurrence of NMSC is increasing by 10% per year